Dr T. Comeau , MD

6.3K posts

Dr T. Comeau , MD banner
Dr T. Comeau , MD

Dr T. Comeau , MD

@SCTNB

Director New Brunswick Stem Cell Transplant Program ; SCT MD ; #hematology: #leukemia, #MDS, #lymphoma, #mmsm , #apheresis, #bmtsm , #immunotherapy , #mpnsm

Canada Katılım Haziran 2011
4.1K Takip Edilen2.9K Takipçiler
Dr T. Comeau , MD
Dr T. Comeau , MD@SCTNB·
Chimeric Antigen Receptor T-Cell Therapy in the Outpatient Setting: An Expert Panel Opinion from the American Society for Transplantation and Cellular Therapy - Transplantation and Cellular Therapy astctjournal.org/article/S2666-…
English
0
0
6
515
Dr T. Comeau , MD
Dr T. Comeau , MD@SCTNB·
Implementation and operational management of marketed chimeric antigen receptor T cell (CAR-T Cell) therapy—a guidance by the GoCART Coalition Pharmacist Working Group | Bone Marrow Transplantation nature.com/articles/s4140…
English
0
0
0
228
Dr T. Comeau , MD
Dr T. Comeau , MD@SCTNB·
Current incidence, severity, and management of veno-occlusive disease/sinusoidal obstruction syndrome in adult allogeneic HSCT recipients: an EBMT Transplant Complications Working Party study | Bone Marrow Transplantation nature.com/articles/s4140…
English
0
2
11
718
Dr T. Comeau , MD
Dr T. Comeau , MD@SCTNB·
Etoposide plus cytarabine versus cyclophosphamide or melphalan in busulfan-based preparative regimens for autologous stem cell transplantation in adults with acute myeloid leukemia in first complete remission: a study from the EBMT nature.com/articles/s4140…
English
0
0
1
284